Statistics

Participants

Total participants

3

Submissions

Total submissions to the Open Development Phase Recurrence phase

3

Total submissions to the Open Development Phase Survival phase

1

Total submissions to the Closed Testing Phase Recurrence phase

0

Total submissions to the Closed Testing Phase Survival phase

0